Health TrialsbyHealthPanel

Adapting a Telehealth Intervention for Suicide Prevention Among Patients With Alcohol Use Disorder in Tanzania

ConditionsAlcohol Use DisorderSuicide Prevention
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDuke University

About this trial

Together, alcohol use and suicide account for approximately 4 million deaths per year, with a considerable burden on low and middle-income countries. Tanzania is among the world's most underserved nations for mental health treatment, with very little capacity to treat suicidality or alcohol use disorders. In this study, the researchers will adapt an evidence-based intervention for suicide prevention to address the unique needs of people with alcohol use disorders in Tanzania, and rigorously pilot test the intervention to assess its feasibility and acceptability in a Tanzanian emergency department.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

18 years of age or older

screen positive for alcohol use disorder (AUDIT >=8)

have had suicidal thinking (C-SSRS item indicating "actual thoughts of suicide") in last 30 days

clinically sober

Disqualifiers

prisoners

decline or unable to complete informed consent

Trial design

Design model

Single group

Treatments tested in this trial

  • IDEAS-AUD

    Behavioral

    Telehealth-delivered counseling to reduce suicide risk among people with Alcohol Use Disorder (AUD) who are presenting for care in the KCMC Emergency Department (ED).

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: IDEAS-AUDExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Acceptability of intervention

Acceptability of Intervention Measure (AIM). Four items scored from 1-Completely disagree to 5-Completely agree. Scores are summed for a total score of 4 to 20, with higher scores indicating greater acceptability.

Time frame
3 months
2

Enrollment feasibility as measured by the percentage of ED patients with documented screening for study eligibility

Time frame
up to 1 year
3

Enrollment feasibility as measured by the number of eligible participants who declined enrollment

Time frame
up to 1 year
4

Enrollment feasibility as measured by the time needed to enroll 30 eligible participants

Time frame
up to 1 year

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Duke University

Lead sponsor

Kilimanjaro Christian Medical Centre, Tanzania

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: